In order to identify the detailed target fraction in CD34+/CD38+ cells that generates APL with PML-RARA, the CD34+/CD38+ cells were then divided into three fractions based on their expression of CD123 and CD45RA; CMP, GMP and MEP (Figure 6F). Here, RARA is linked to acute promyelocytic leukemia.